Results 1 to 10 of about 113,289 (321)
The chronic gastrointestinal manifestations of Chagas disease [PDF]
Clinics, 2009 Chagas disease is an infectious disease caused by the protozoan Trypanosoma cruzi. The disease mainly affects the nervous system, digestive system and heart.
Nilce Mitiko Matsuda +2 more
doaj +5 more sources
Congenital Chagas disease: A cohort study to assess molecular diagnostic methods at the Chagas disease national reference center of Argentina. [PDF]
PLoS Neglected Tropical DiseasesBackgroundTrypanosoma cruzi is a protozoan parasite which causes Chagas disease. Mother-to-child transmission is the main route of transmission in vector-free areas.
Constanza Lopez-Albizu +6 more
doaj +2 more sources
Predictors of Incident Heart Failure in Patients With Chronic Chagas Disease Cardiomyopathy. [PDF]
EchocardiographyWhile most clinical parameters were not associated with incident heart failure (HF) in patients with chronic Chagas disease cardiomyopathy, echocardiographic parameters, including LV systolic and strain‐derived parameters, were associated with incident HF. This knowledge can be very useful for planning the care and follow‐up of these patients. ABSTRACT
Cunha DMD +10 more
europepmc +2 more sources
Congenital Transmission of Chagas Disease in Latin American Immigrants in Switzerland [PDF]
Emerging Infectious Diseases, 2009 International migration has changed the epidemiologic patterns of Chagas disease. Recently, 2 cases of Chagas disease transmitted from Latin American women to their newborns were diagnosed in Geneva, Switzerland.
Yves Jackson +7 more
doaj +3 more sources
Clinical features of Chagas disease progression and severity. [PDF]
Lancet Reg Health AmChagas disease, the most common form of nonischaemic cardiomyopathy globally, is one of the leading causes of morbidity and mortality in Latin America. Chagas cardiomyopathy has a wide clinical spectrum and prognosis, which is primarily determined by the
Nunes MCP +4 more
europepmc +4 more sources
The costs of preventing and treating chagas disease in Colombia [PDF]
, 2008 Background: The objective of this study is to report the costs of Chagas disease in Colombia, in terms of vector disease control programmes and the costs of providing care to chronic Chagas disease patients with cardiomyopathy.
A Kroeger +39 more
core +25 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background Chagas disease (CD) presents an ominous prognosis. The predictive value of biomarkers and new echocardiogram parameters in adjusted models have not been well studied.
Veronica G. Mendes +21 more
doaj +1 more source
Pediatrics In Review, 2016 Approximately 8 million people worldwide are infected by the protozoan parasite Trypanosoma cruzi, the causative agent of Chagas disease. After a latent period that can last years or decades, 10% to 30% of infected people develop serious complications, such as cardiomyopathy or gastrointestinal dysfunction.
Tustin, Aaron W., Bowman, Natalie M.
openaire +2 more sources
Stroke in Chagas disease: from pathophysiology to clinical practice [PDF]
Revista da Sociedade Brasileira de Medicina Tropical, 2022 Despite substantial progress toward its control, Chagas disease continues to be a major public health problem in Latin America and has become a global health concern.
Thaís Aparecida Reis Lage +6 more
doaj +1 more source
Food Science &Nutrition, Volume 11, Issue 1, Page 191-203, January 2023., 2023 The IOP‐A has a hypolipidemic effect, which may be due to its ability to regulate the expression of CYP7A1 and SREBP‐1c, as well as to correct an imbalance in the structure of the intestinal microflora. Abstract The purpose of this study was to observe the effect of Inonotus obliquus polysaccharide (IOP) on blood lipids and its regulation on the ...
Fengyuan Lin +7 more
wiley +1 more source